These findings indicated that the 2′-O-methyl-modified siRNA-lipoplexes achieved the targeted silencing of the PECAM-1 gene in the vasculature of the lung adenocarcinoma xenografts in vivo. Here, PECAM1 is linked to lung adenocarcinoma.